BTW
DOX icon

Boston Trust Walden’s Amdocs DOX Stock Holding History

Boston Trust Walden’s Portfolio DOX Stock Details DOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
54,635
-587,930
-91% -$36.1M 0.02% 248
2026
Q1 		$41.9M Sell
642,565
-16,462
-2% -$1.2M 0.34% 109
2025
Q4 		$53.1M Sell
659,027
-19,591
-3% -$1.58M 0.4% 92
2025
Q3 		$55.7M Sell
678,618
-311
-0% -$27K 0.41% 96
2025
Q2 		$61.9M Buy
678,929
+37,835
+6% +$3.38M 0.44% 84
2025
Q1 		$58.7M Sell
641,094
-769
-0.1% -$67.1K 0.43% 83
2024
Q4 		$54.6M Buy
641,863
+21,154
+3% +$1.86M 0.38% 94
2024
Q3 		$54.3M Buy
620,709
+2,322
+0.4% +$195K 0.38% 104
2024
Q2 		$48.8M Buy
618,387
+89,726
+17% +$7.37M 0.36% 114
2024
Q1 		$47.8M Buy
528,661
+2,710
+0.5% +$247K 0.34% 119
2023
Q4 		$46.2M Buy
525,951
+16,278
+3% +$1.36M 0.35% 109
2023
Q3 		$43.1M Buy
509,673
+2,439
+0.5% +$220K 0.36% 102
2023
Q2 		$50.1M Buy
507,234
+32,305
+7% +$3.04M 0.41% 90
2023
Q1 		$45.6M Buy
474,929
+9,300
+2% +$860K 0.39% 92
2022
Q4 		$42.3M Buy
465,629
+7,539
+2% +$641K 0.37% 94
2022
Q3 		$36.4M Sell
458,090
-3,319
-0.7% -$281K 0.36% 99
2022
Q2 		$38.4M Buy
461,409
+4,351
+1% +$359K 0.36% 99
2022
Q1 		$37.6M Buy
457,058
+136,718
+43% +$10.7M 0.31% 115
2021
Q4 		$24M Buy
320,340
+1,647
+0.5% +$124K 0.19% 165
2021
Q3 		$24.1M Sell
318,693
-5,463
-2% -$423K 0.21% 158
2021
Q2 		$25.1M Buy
324,156
+19,847
+7% +$1.53M 0.22% 157
2021
Q1 		$21.3M Buy
304,309
+92,617
+44% +$7M 0.21% 158
2020
Q4 		$15M Buy
211,692
+134
+0.1% +$8.41K 0.16% 181
2020
Q3 		$12.1M Buy
211,558
+2,283
+1% +$136K 0.15% 179
2020
Q2 		$12.7M Buy
209,275
+3,862
+2% +$239K 0.17% 178
2020
Q1 		$11.3M Buy
205,413
+729
+0.4% +$48.9K 0.18% 165
2019
Q4 		$14.8M Sell
204,684
-59,064
-22% -$4.02M 0.17% 172
2019
Q3 		$17.4M Buy
263,748
+4,675
+2% +$300K 0.22% 143
2019
Q2 		$16.1M Buy
259,073
+25,637
+11% +$1.48M 0.21% 140
2019
Q1 		$12.6M Buy
233,436
+9,545
+4% +$537K 0.17% 166
2018
Q4 		$13.1M Buy
223,891
+17,172
+8% +$1.08M 0.21% 140
2018
Q3 		$13.6M Buy
206,719
+5,882
+3% +$389K 0.19% 151
2018
Q2 		$13.3M Buy
200,837
+12,880
+7% +$867K 0.2% 149
2018
Q1 		$12.5M Buy
187,957
+1,576
+0.8% +$106K 0.19% 151
2017
Q4 		$12.2M Buy
186,381
+3,067
+2% +$199K 0.18% 161
2017
Q3 		$11.8M Buy
183,314
+1,209
+0.7% +$78.1K 0.18% 157
2017
Q2 		$11.7M Buy
182,105
+19,781
+12% +$1.25M 0.19% 155
2017
Q1 		$9.9M Sell
162,324
-892
-0.5% -$53.6K 0.15% 177
2016
Q4 		$9.51M Buy
163,216
+39,602
+32% +$2.34M 0.15% 180
2016
Q3 		$7.15M Sell
123,614
-928
-0.7% -$54.7K 0.12% 197
2016
Q2 		$7.19M Sell
124,542
-2,446
-2% -$140K 0.12% 193
2016
Q1 		$7.67M Buy
+126,988
New +$7.11M 0.13% 195

Other funds holding DOX

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Boston Trust Walden's DOX Position: Q2 2026 in Review

Boston Trust Walden reduced its Amdocs (DOX) stake by 91% in Q2 2026, selling an estimated $36.1M and leaving 54,635 shares worth $2.76M. The position accounts for 0.02% of the portfolio, ranked #248.

Boston Trust Walden first reported a position in DOX in Q1 2016 and has held it in 42 quarters since. The position peaked at $61.9M in Q2 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Boston Trust Walden held 54,635 shares of Amdocs worth $2.76M as of Q2 2026.
  • Boston Trust Walden sold 587,930 Amdocs shares in Q2 2026, an estimated $36.1M.
  • Amdocs made up 0.02% of Boston Trust Walden's portfolio in Q2 2026, its #248 holding.
  • Boston Trust Walden first reported a position in Amdocs in Q1 2016 and has held it in 42 quarters since.
  • Boston Trust Walden's Amdocs position peaked at $61.9M in Q2 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.